An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial

Gespeichert in:
Bibliographische Detailangaben
Weitere Verfasser: Wang, Thomas H. (BerichterstatterIn) , Hacke, Werner (BerichterstatterIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2007
In: European heart journal
Year: 2007, Jahrgang: 28, Heft: 18, Pages: 2200-7
ISSN:1522-9645
DOI:10.1093/eurheartj/ehm274
Online-Zugang:Resolving-System, kostenfrei, Volltext: http://eurheartj.oxfordjournals.org/content/ehj/28/18/2200.full.pdf
Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1093/eurheartj/ehm274
Volltext
Verfasserangaben:Thomas H. Wang ... Werner Hacke...

MARC

LEADER 00000caa a2200000 c 4500
001 1493527312
003 DE-627
005 20220811155914.0
007 cr uuu---uuuuu
008 141216s2007 xx |||||o 00| ||eng c
024 7 |a 10.1093/eurheartj/ehm274  |2 doi 
035 |a (DE-627)1493527312 
035 |a (DE-576)423527312 
035 |a (DE-599)BSZ423527312 
035 |a (OCoLC)1340655576 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
084 |a 33  |2 sdnb 
245 0 3 |a An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial  |c Thomas H. Wang ... Werner Hacke... 
264 1 |c 2007 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 16.12.2014 
700 1 |a Wang, Thomas H.  |0 (DE-588)1063983002  |0 (DE-627)812790723  |0 (DE-576)423527134  |4 oth 
700 1 |a Hacke, Werner  |d 1948-  |0 (DE-588)12021699X  |0 (DE-627)080530346  |0 (DE-576)164358854  |4 oth 
773 0 8 |i In  |t European heart journal  |d Oxford : Oxford University Press, 1980  |g 28(2007), 18, Seite 2200-7  |h Online-Ressource  |w (DE-627)320415813  |w (DE-600)2001908-7  |w (DE-576)103746846  |x 1522-9645  |7 nnas  |a An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial 
773 1 8 |g volume:28  |g year:2007  |g number:18  |g pages:2200-7  |g extent:8  |a An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial 
856 4 0 |u http://eurheartj.oxfordjournals.org/content/ehj/28/18/2200.full.pdf  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://dx.doi.org/10.1093/eurheartj/ehm274  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20141216 
993 |a Article 
994 |a 2007 
998 |g 12021699X  |a Hacke, Werner  |m 12021699X:Hacke, Werner  |d 910000  |d 911100  |e 910000PH12021699X  |e 911100PH12021699X  |k 0/910000/  |k 1/910000/911100/  |p 6 
999 |a KXP-PPN1493527312  |e 2827047330 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Thomas H. Wang ... Werner Hacke..."]},"relHost":[{"recId":"320415813","origin":[{"dateIssuedDisp":"1980-","publisher":"Oxford University Press ; Harcourt","dateIssuedKey":"1980","publisherPlace":"Oxford ; London [u.a.]"}],"pubHistory":["1.1980 -"],"disp":"An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trialEuropean heart journal","id":{"issn":["1522-9645"],"zdb":["2001908-7"],"eki":["320415813"]},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 12.09.2017"],"part":{"year":"2007","text":"28(2007), 18, Seite 2200-7","extent":"8","issue":"18","volume":"28","pages":"2200-7"},"title":[{"title":"European heart journal","title_sort":"European heart journal"}]}],"origin":[{"dateIssuedDisp":"2007","dateIssuedKey":"2007"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 16.12.2014"],"person":[{"given":"Thomas H.","role":"oth","family":"Wang","display":"Wang, Thomas H."},{"family":"Hacke","display":"Hacke, Werner","role":"oth","given":"Werner"}],"title":[{"title_sort":"analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial","title":"An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial"}],"recId":"1493527312","id":{"eki":["1493527312"],"doi":["10.1093/eurheartj/ehm274"]},"language":["eng"],"physDesc":[{"extent":"8 S."}]} 
SRT |a ANALYSISOF2007